Nancy Valente

Director, Myovant Sciences Ltd.

Companies

Xencor IncEVP, Chief Development Officer May 3, 2023 to now¹
Myovant Sciences Ltd.Board member Nov 9, 2021 to Mar 10, 2023²
Xencor IncBoard member Sep 9, 2022 to Sep 9, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Xencor Inc XNCR49,169 shares⁴$1.1M at $23.18May 2, 2025
Myovant Sciences Ltd.0 shares⁵Mar 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 2, 2025Sold 4,616 shares at $11.03 of Xencor Inc⁴
Mar 10, 2025Sold 2,565 shares at $13.60 of Xencor Inc⁶
May 2, 2024Sold 4,745 shares at $23.58 of Xencor Inc⁷
Mar 5, 2024Granted 19,634 shares of Xencor Inc⁸
May 1, 2023Granted 39,296 shares of Xencor Inc⁹
Mar 10, 2023Returned to company 3,673 shares of Myovant Sciences Ltd.⁵
Oct 26, 2022Granted 9,859 shares of Myovant Sciences Ltd.¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARXencor Inc, EVP, Chief Development Officer
2
SEC EDGARMyovant Sciences Ltd., Board member
3
SEC EDGARXencor Inc, Board member
4
SEC EDGARXencor Inc shares after the filing of May 2, 2025
5
SEC EDGARMyovant Sciences Ltd. shares after the filing of Mar 10, 2023
6
SEC EDGARForm 4 filed Mar 11, 2025
7
SEC EDGARForm 4 filed May 3, 2024
8
SEC EDGARForm 4 filed Mar 7, 2024
9
SEC EDGARForm 4 filed May 3, 2023
10
SEC EDGARForm 4 filed Oct 28, 2022